SCHEMBL13005177

SCHEMBL13005177

COC(=O)C(C)(C)c1ccc(S(=O)(=O)Cl)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 3/20 0.43
CNR1 P21554 1/20 0.43
CNR2 P34972 1/20 0.43
BRS3 P32247 1/20 0.42
RORC P51449 1/20 0.40
CYP2C19 P33261 1/20 0.39
KCNN4 O15554 1/20 0.38
PLCG1 P19174 1/20 0.37
ALDH1A1 P00352 6/20 0.37
HSD17B10 Q99714 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
NR3C2 P08235 1/20 0.36
POLB P06746 2/20 0.36
HSD11B1 P28845 1/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
MAPT P10636 2/20 0.35
RECQL P46063 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8974321 0.83 CNR1 (0.54) ELANECNR1CNR2BRS3CYP2C19
SCHEMBL25516350 0.83 CA2 (0.51) CNR1CNR2MEN1KMT2AMAPT
SCHEMBL6292770 0.82 RORC (0.55) ELANECNR2RORCPOLBMEN1
SCHEMBL168480 0.81 RORC (0.57) ELANECNR1CNR2RORCMAPT
SCHEMBL18300622 0.80 ALDH1A1 (0.45) ELANERORCALDH1A1HSD17B10TDP1
SCHEMBL6825088 0.78 POLB (0.50) ELANECNR1CNR2BRS3CYP2C19
SCHEMBL5877921 0.77 MAPT (0.50) CNR1CNR2BRS3KCNN4ALDH1A1
SCHEMBL4676395 0.76 TRPV4 (0.54) CNR1CNR2ALDH1A1MAPTNPSR1
SCHEMBL1107149 0.76 CNR2 (0.57) CNR1CNR2BRS3KCNN4PLCG1
SCHEMBL3573740 0.76 CNR1 (0.53) ELANECNR1CNR2BRS3KCNN4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415480-B2 Thiazolidine carboxamide derivatives as modulators of the prostaglandin F receptor MERCK SERONO SA (CH) 2013-04-09 US disclosed
US-8415480-B2 Thiazolidine carboxamide derivatives as modulators of the prostaglandin F receptor MERCK SERONO SA (CH) 2013-04-09 US disclosed
EP-1487442-B1 THIAZOLIDINE CARBOXAMIDE DERIVATIVES AS MODULATORS OF THE PROSTAGLANDIN F RECEPTOR MERCK SERONO SA (CH) 2010-12-01 EP disclosed
US-20090215749-A9 THIAZOLIDINE CARBOXAMIDE DERIVATIVES AS MODULATORS OF THE PROSTAGLANDIN F RECEPTOR LABORATOIRES SERONO S.A. (CH) 2009-08-27 US disclosed
US-20090215749-A9 THIAZOLIDINE CARBOXAMIDE DERIVATIVES AS MODULATORS OF THE PROSTAGLANDIN F RECEPTOR LABORATOIRES SERONO S.A. (CH) 2009-08-27 US disclosed
US-20080255094-A1 THIAZOLIDINE CARBOXAMIDE DERIVATIVES AS MODULATORS OF THE PROSTAGLANDIN F RECEPTOR LABORATOIRES SERONO S.A. (CH) 2008-10-16 US disclosed
US-20080255094-A1 THIAZOLIDINE CARBOXAMIDE DERIVATIVES AS MODULATORS OF THE PROSTAGLANDIN F RECEPTOR LABORATOIRES SERONO S.A. (CH) 2008-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215749-A9 THIAZOLIDINE CARBOXAMIDE DERIVATIVES AS MODULATORS OF THE PROSTAGLANDIN F RECEPTOR PTGER4, PTGER2, PTGER1 ELANE 3522/4885CNR1 59/4885CNR2 23/4885
US-20080255094-A1 THIAZOLIDINE CARBOXAMIDE DERIVATIVES AS MODULATORS OF THE PROSTAGLANDIN F RECEPTOR PTGER4, PTGER2, PTGER1 ELANE 3522/4885CNR1 59/4885CNR2 23/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.